Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01826942 · ClinicalTrials.gov registry record · NA
Scar Prevention Using Fractional Carbon Dioxide Laser Treatment
A NA study, sponsored by Lumenis Be.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT01826942 is a NA study that was terminated before completion, run by Lumenis Be. The registered enrollment target is 10 participants.
The verdict
NCT01826942, a NA study, was terminated before completion, sponsored by Lumenis Be.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also evaluate the effect of shallow fractional laser treatment versus deep parameters settings. If effective treatments could be performed at time of surgery, this would result in both time and cost saving to the patient and to the healthcare system and will improve patient's self-image post surgeries.
Interventions
- DEVICE Lumenis UltraPulse single fractional CO2 laser treatment thin skin
- DEVICE Single fractional CO2 treatment at surgical area closure procedure on thick skin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-01 |
| Est. Completion | 2013-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01826942
The ClinicalTrials.gov registry entry for NCT01826942 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Lumenis Be, which has 20 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Lumenis UltraPulse single fractional CO2 laser treatment thin skin is the first listed.
NCT01826942 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01826942 about?
NCT01826942 is a clinical study titled "Scar Prevention Using Fractional Carbon Dioxide Laser Treatment". In this study the investigators intend to determine the impact of fractional CO2 laser treatment on the edges of a fresh wound during surgical area closure on thin skin (e.g. face, hands, arms, thorax, etc.) and on thick skin (abdominoplasty procedure) on scar formation. The investigators will also ...
What is the current status of trial NCT01826942?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2013-01. Estimated completion is 2013-03.
What interventions are being tested in trial NCT01826942?
The interventions under investigation include: Lumenis UltraPulse single fractional CO2 laser treatment thin skin (DEVICE), Single fractional CO2 treatment at surgical area closure procedure on thick skin (DEVICE).
Who is sponsoring clinical trial NCT01826942?
This trial is sponsored by Lumenis Be, which has 20 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.